IL-10 promoter genetic polymorphisms and risk of Kawasaki disease in Taiwan

Disease Markers

Volumn 30, Issue 1, 2011, Pages 51-59

  Hsieh, Kai Sheng ^a   Lai, Tsung Jen ^a,b,c   Hwang, Yu Tung ^a,d   Lin, Ming Wei ^c   Weng, Ken Pen ^a,e   Chiu, Yi Ten ^a,b   Ho, Tsyr Yuh ^e   Chen, Chi Shan ^a   Shiue, Yow Ling ^b   Hsiao, Michael ^f   Tsai, Shih Feng ^c,g   Ger, Luo Ping ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Department of Cardiology   (Taiwan)

^e ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

and case control study; case parent trio study; IL 10; Kawasaki disease; risk; single nucleotide polymorphisms

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

EID: 79955115477     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0765     Document Type: Article

References (33)

1. D. Burgner and A. Harnden, Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 9 (2005), 185-194. (Pubitemid 40827159)
2. Y. Fujita, Y. Nakamura, K. Sakata, N. Hara, M. Kobayashi and M. Nagai et al., Kawasaki disease in families, Pediatrics 84 (1989), 666-669. (Pubitemid 19237567)
3. CL. Wang, YT. Wu, CA. Liu, H.C. Kuo and K.D. Yang, Kawasaki disease: infection, immunity and genetics, Pediatr Infect Dis J 24 (2005), 998-1004. (Pubitemid 41689607)
4. D.S. Kim, H.K. Lee, G.W. Noh, S.I. Lee and K.Y Lee, Increased serum interleukin-10 level in Kawasaki disease, Yonsei Medical Journal 37 (1996), 125-130. (Pubitemid 126450976)
5. CY. Lin, CC. Lin, B. Hwang and B. Chiang, Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease, The Journal of Pediatrics 121 (1992), 924-926.
6. CP. Maury, E. Salo and P. Pelkonen, Circulating interleukin1 beta in patients with Kawasaki disease, The New England Journal ofMedicine 319 (1988), 1670-1671. (Pubitemid 19015243)
7. H. Tsukahara, M. Hiraoka, M. Saito, K. Nishida, R. Koba-ta, S. Tsuchida, M. Toyooka, H. Kimura, F. Gejyo and M. Mayumi, Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease, Pediatr Int 42 (2000), 236-240. (Pubitemid 30409335)
8. G.W. Noh, W.G. Lee, W. Lee and K. Lee, Effects of intra-venous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease, Immunology letters 62 (1998), 19-24. (Pubitemid 28277392)
9. K.W. Moore, R. de Waal Malefyt, R.L. Coffman and A. O'Garra, Interleukin-10 and the interleukin-10 receptor, An-nual Review of Immunology 19 (2001), 683-765. (Pubitemid 32368050)
10. T.R. Mosmann, Properties and functions of interleukin-10, Advances in Immunology 56 (1994), 1-26. (Pubitemid 24242221)
11. R. de Waal Malefyt, J. Abrams, B. Bennett, C.G. Figdor and J.E. de Vries, Interleukin 10 (IL-10) inhibits cytokine synthe-sis by human monocytes: an autoregulatory role of IL-10 pro-duced by monocytes, The Journal of Experimental Medicine 174(1991), 1209-1220.
12. L. Ding and E.M. Shevach, IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage cos-timulatory function, J Immunol 148 (1992), 3133-3139.
13. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard and A. O'Garra, IL-10 inhibits cytokine production by activated macrophages, J Immunol 147 (1991), 3815-3822.
14. D.H. Hsu, K.W. Moore and H. Spits, Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity, International Immunolo-gy 4 (1992), 563-569.
15. K. Itoh and S. Hirohata, The role of IL-10 in human B cell activation, proliferation, and differentiation, J Immunol 154 (1995), 4341-4350.
16. J. Eskdale, D. Kube, H. Tesch and G. Gallagher, Mapping of the human IL10 gene and further characterization ofthe 5' flanking sequence, Immunogenetics 46 (1997), 120-128. (Pubitemid 27234709)
17. J. Eskdale, G. Gallagher, CL. Verweij, V. Keijsers, R.G. West-endorp and T.W. Huizinga, Interleukin 10 secretion in relation to human IL-10 locus haplotypes, Proceedings ofthe Nation-al Academy ofSciences ofthe United States of America 95 (1998), 9465-9470. (Pubitemid 28506254)
18. H.S. Jin, H.B. Kim, B.S. Kim, J.K. Lee, EJ. Seo, H.W. Yoo, I.S. Park, YM. Hong and SJ. Hong, The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease, Pediatric Research 61 (2007), 584-587. (Pubitemid 46650011)
19. K. Koss, J. Satsangi, G.C. Fanning, K.I. Welsh andD.P Jewell, Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differen-tial effects on production and allele frequencies, Genes and Immunity 1 (2000), 185-190.
20. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, PJ. Sinnott and I.V. Hutchinson, An investigation of polymor-phism inthe interleukin-10 gene promoter, Eur J Immunogenet 24 (1997), 1-8. (Pubitemid 27050850)
21. J. Yang, C.R. Li, YB. Li, R.X. Li, L.B. Sun, HJ. Huang and G.B. Wang, The correlation between Kawasaki dis-ease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter, Zhonghua erkezazhi 41 (2003), 598-602.
22. K.C. Hsueh, YJ. Lin, J.S. Chang, L. Wan, YH. Tsai, CH. Tsai, CP. Chen and FJ. Tsai, Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease, Journal ofKorean Medical Science 24 (2009), 438-442.
23. K.P Weng, K.S. Hsieh, YT. Hwang, S.H. Huang, TJ. Lai, YS. Yuh, YY Hou, CC. Lin, S.C. Huang and CK. Chang, IL-10 polymorphisms are associated with coronary artery lesions in acute stage ofKawasaki disease, Circ J74 983-989.
24. H. Zhao, J. Li and W.P. Robinson, Multipoint genetic mapping with uniparental disomy data, American Journal ofHuman Genetics 67 (2000), 851-861.
25. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi and I. Golani, Controlling the false discovery rate in behavior genetics re-search, Behav Brain Res 125 (2001), 279-284 (Pubitemid 33000466)
26. N.M. Laird and C. Lange, Family-based designs in the age of large-scale gene-association studies, Nature Reviews 7 (2006), 385-394.
27. E. Crawley, R. Kay, J. Sillibourne, P. Patel, I. Hutchinson and P. Woo, Polymorphic haplotypes ofthe interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes ofjuvenile rheumatoid arthritis, Arthritis andRheumatism 42 (1999), 1101-1108. (Pubitemid 29268946)
28. CJ. Edwards-Smith, J.R. Jonsson, D.M. Purdie, A. Bansal, C. Shorthouse and E.E. Powell, Interleukin-10 promoter poly-morphism predicts initial response of chronic hepatitis C to interferon alfa, Hepatology 30 (1999), 526-530. (Pubitemid 29357520)
29. A.H. Rowley, S.T. Shulman, CA. Mask, L.S. Finn, M. Terai, S.C. Baker, CA. Galliani, K. Takahashi, S. Naoe, M.B. Kalelkar and S.E. Crawford, Ig A plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease, The Journal of Infectious Diseases 182 (2000), 1183-1191.
30. A.H. Rowley, S.T. Shulman, B.T. Spike, CA. Mask and S.C. Baker, Oligoclonal Ig A response in the vascular wall in acute Kawasaki disease, J Immunol 166 (2001), 1334-1343. (Pubitemid 32060296)
31. S. Furukawa, T. Matsubara, K. Jujoh, K. Yone, T. Sugawara, K. Sasai, H. Kato and K. Yabuta, Peripheral blood mono-cyte/macrophages and serum tumor necrosis factor in Kawasa-ki disease, Clin Immunol Immunopathol 48 (1988), 247-251.
32. Y. Ueno, N. Takano, H. Kanegane, T. Yokoi, A. Yachie, T. Miyawaki and N. Taniguchi, The acute-phase nature of inter-leukin 6: studies in Kawasaki disease and other febrile illness-es, Clin Exp Immunol 76 (1989), 337-342. (Pubitemid 19172259)
33. Y. Okada, M. Shinohara, T. Kobayashi, Y Inoue, T. Tomomasa, T. Kobayashi and A. Morikawa, Effect ofcorticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children, J Pediatr 143 (2003), 363-367. (Pubitemid 37188322)